Neurotech SA
This article was originally published in Start Up
Executive Summary
Neurotech is making use of the angiogenic properties of tumors to eradicate them. Beyond brain tumors, Neurotech is targeting other conditions where angiogenesis is important, for example, ischemic stroke. Neuortech's approach is also suited to a variety of other neurological disorders, including Alzheimer's disease and Parkinson's disease.
You may also be interested in...
Planet Neuron: Start-Ups in Neurobiology
New drug discovery tools promise to shorten the distance between mouse and man while new neurology drugs remain on the distant horizon. Meanwhile, licensing keeps start-ups going.
Wound Solutions Ltd.
Wound Solutions Ltd. looks to the paradigm of patient self-care in diabetes to address the gaps in chronic wound care, where the feedback provided by blood glucose monitoring encourages changes in behavior. A small device that is placed under a compression bandage helps patients with venous leg ulcers comply with the steps they should be taking to support wound healing, in the process, collecting data that helps clinicians make informed therapy decisions.
Patient-Centric Devices Promise Cost-Efficient Advanced Wound Care
The treatment of chronic wounds is challenging, not only because of the underlying biology, but also because of more practical considerations: fragmentation in the care settings, the logistics of delivering products to patients, and the costs of chronic care. Next generation advanced wound care companies are engineering solutions to these problems.